Arlington secures pharma company for Uxbridge HQ
Developer and asset manager Arlington has signed Tokyo-based pharma group Daiichi Sankyo for its new UK headquarters at Uxbridge Business Park, in west London.
The pharmaceutical company is taking 10,854 sq ft on the second floor of Building 4 on the business park, and has agreed a 10-year lease. It is relocating from Gerrards Cross.
Manuel Reiberg, general manager of Daiichi Sankyo UK, said: “As a company we are very excited about how the head office relocation will help provide the springboard to take our organisation to the next level.
Developer and asset manager Arlington has signed Tokyo-based pharma group Daiichi Sankyo for its new UK headquarters at Uxbridge Business Park, in west London.
The pharmaceutical company is taking 10,854 sq ft on the second floor of Building 4 on the business park, and has agreed a 10-year lease. It is relocating from Gerrards Cross.
Manuel Reiberg, general manager of Daiichi Sankyo UK, said: “As a company we are very excited about how the head office relocation will help provide the springboard to take our organisation to the next level.
“The organisation has been undergoing significant growth during the past three years and we believe that Uxbridge Business Park’s facilities, premium office setting and connectivity to London will help to sustain and support that projected growth.”
The business park features an amenity hub, including meeting rooms, studio space and restaurant alongside sports facilities with an all-weather five-a-side pitch and multi-use games area. These are run by a full-time lifestyle manager.
The tenant line-up also includes Amgen, Bristol-Myers Squibb, Mondelēz, Xerox and LifeScan.
Earlier this year, Arlington added to its offer by launching a co-working concept at the park.
JLL acted for Daiichi Sankyo, while Arlington was represented by BNP PRE.
To send feedback, e-mail pui-guan.man@egi.co.uk or tweet @PuiGuanM or @estatesgazette
